Cargando…

Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation

The condensation of chlorides of substituted pyrazinecarboxylic acids with ring-substituted anilines yielded twelve substituted pyrazinecarboxylic acid amides. The synthetic approach, analytical, and lipophilicity data of the newly synthesized compounds are presented. Two antituberculosis assays wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Doležal, Martin, Zitko, Jan, Kešetovičová, Diana, Kuneš, Jiří, Svobodová, Michaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255326/
https://www.ncbi.nlm.nih.gov/pubmed/19924056
http://dx.doi.org/10.3390/molecules14104180
_version_ 1783373913881837568
author Doležal, Martin
Zitko, Jan
Kešetovičová, Diana
Kuneš, Jiří
Svobodová, Michaela
author_facet Doležal, Martin
Zitko, Jan
Kešetovičová, Diana
Kuneš, Jiří
Svobodová, Michaela
author_sort Doležal, Martin
collection PubMed
description The condensation of chlorides of substituted pyrazinecarboxylic acids with ring-substituted anilines yielded twelve substituted pyrazinecarboxylic acid amides. The synthetic approach, analytical, and lipophilicity data of the newly synthesized compounds are presented. Two antituberculosis assays were used. Firstly, the antimycobacterial activity against four different Mycobacterium strains in a series of pyrazine derivatives was investigated. Secondly, the antimycobacterial evaluation was performed at the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) program. Interesting in vitro antimycobacterial activity was found, N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide (9) was most active derivative compound against M. tuberculosis (MIC < 2.0 μmol/L), while another iodo derivative 5-tert-butyl-6-chloro-N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide (12) was the most active compound in the TAACF antituberculosis screening program (IC(90) = 0.819 µg/mL).
format Online
Article
Text
id pubmed-6255326
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-62553262018-11-30 Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation Doležal, Martin Zitko, Jan Kešetovičová, Diana Kuneš, Jiří Svobodová, Michaela Molecules Article The condensation of chlorides of substituted pyrazinecarboxylic acids with ring-substituted anilines yielded twelve substituted pyrazinecarboxylic acid amides. The synthetic approach, analytical, and lipophilicity data of the newly synthesized compounds are presented. Two antituberculosis assays were used. Firstly, the antimycobacterial activity against four different Mycobacterium strains in a series of pyrazine derivatives was investigated. Secondly, the antimycobacterial evaluation was performed at the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) program. Interesting in vitro antimycobacterial activity was found, N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide (9) was most active derivative compound against M. tuberculosis (MIC < 2.0 μmol/L), while another iodo derivative 5-tert-butyl-6-chloro-N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide (12) was the most active compound in the TAACF antituberculosis screening program (IC(90) = 0.819 µg/mL). Molecular Diversity Preservation International 2009-10-20 /pmc/articles/PMC6255326/ /pubmed/19924056 http://dx.doi.org/10.3390/molecules14104180 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Doležal, Martin
Zitko, Jan
Kešetovičová, Diana
Kuneš, Jiří
Svobodová, Michaela
Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation
title Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation
title_full Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation
title_fullStr Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation
title_full_unstemmed Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation
title_short Substituted N-Phenylpyrazine-2-carboxamides: Synthesis and Antimycobacterial Evaluation
title_sort substituted n-phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255326/
https://www.ncbi.nlm.nih.gov/pubmed/19924056
http://dx.doi.org/10.3390/molecules14104180
work_keys_str_mv AT dolezalmartin substitutednphenylpyrazine2carboxamidessynthesisandantimycobacterialevaluation
AT zitkojan substitutednphenylpyrazine2carboxamidessynthesisandantimycobacterialevaluation
AT kesetovicovadiana substitutednphenylpyrazine2carboxamidessynthesisandantimycobacterialevaluation
AT kunesjiri substitutednphenylpyrazine2carboxamidessynthesisandantimycobacterialevaluation
AT svobodovamichaela substitutednphenylpyrazine2carboxamidessynthesisandantimycobacterialevaluation